Producer
Ethicon (Johnson & Johnson MedTech)
J&J's surgical products subsidiary; world's largest manufacturer of sutures, wound closure, and surgical stapling devices; Vicryl® absorbable suture controls the largest share of the global suture market; also makes electrosurgical devices and surgical mesh.
0
Inputs supplied
0
Goods downstream
1
Facilities
0
Stories
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Absorbable Sutures
35%Non-Absorbable Sutures
20%Surgical Stapling
25%Energy-Based Devices
12%Wound Closure & Mesh
8%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Did you know2023
The polyglycolic acid (PGA) chemistry in Ethicon Vicryl absorbable sutures is the same fundamental polymer used in biodegradable food packaging, drug delivery microspheres for cancer chemotherapy, and tissue engineering scaffolds for regenerative medicine. Ethicon's decades of PGA suture manufacturing created the industrial knowledge base for producing reliable, reproducible absorbable polymers -- which then enabled pharmaceutical companies (using PGA/PLGA microspheres) and food packaging companies (using PGA barrier coatings on bottles) to access the same chemistry. A surgeon placing a Vicryl suture and a pharmaceutical researcher loading doxorubicin into PGA microspheres are using material systems whose manufacturing feasibility was demonstrated by Ethicon's suture production scale-up in the 1970s.
Johnson & Johnson MedTech (Ethicon) ↗Chokepoint2021
Ethicon's Vicryl suture is so dominant that many surgeons don't know the generic name — polyglycolic acid — and wouldn't know how to specify an equivalent from a competitor Johnson & Johnson's Ethicon subsidiary invented synthetic absorbable suture (Dexon, then Vicryl) in the late 1960s and early 1970s, displacing the prior standard of catgut (sheep intestine submucosa) that had been used since antiquity. Vicryl (polyglactin 910, a copolymer of PGA and PLA) became so dominant that it is often specified by brand name in surgical technique texts. Ethicon holds ~50%+ of the global suture market. The FDA has approved fewer than 10 competitor manufacturers for equivalent polyglycolic acid sutures; switching requires surgeon re-training and hospital formulary approvals. During J&J's 2020-21 supply chain disruptions, several health systems reported inability to substitute Vicryl despite clinically equivalent alternatives being commercially available.
Journal of Biomedical Materials Research ↗Origin2023
Ethicon was founded in 1922 in Somerville, New Jersey by a group of physicians and entrepreneurs who wanted to standardize surgical sutures -- at the time, surgeons used everything from silk to catgut (made from sheep intestines) to horsehair, with no quality controls or standardization. Ethicon brought industrial quality management to suture manufacturing, producing sterile, calibrated sutures in standardized packaging. Johnson and Johnson acquired Ethicon in 1949, integrating it with J&J's existing bandage and wound care business. The key product innovation came in 1974 when Ethicon launched Vicryl, the first synthetic absorbable suture, replacing catgut with a polyglycolic acid polymer that degrades predictably in 60-90 days. Vicryl became the world's most widely used suture and remains so 50 years later.
Johnson & Johnson MedTech (Ethicon) ↗